Zealand Pharma A/S Stock: price and insider trades · Denmark
No insider purchase over the last 90 days. The latest, by Unknown, was filed 07 Dec 2023.
Zealand Pharma A/S: what insiders have been doing
Zealand Pharma A/S, classified in the Healthcare & Pharma sector, is a listed company based in Glostrup, Denmark, founded in 1998. Its latest reported headcount is 235 employees (2023). Its insiders report their share dealings to Finanstilsynet DK. Between 8 November 2025 and 8 November 2026, 5 insiders published 9 filings.
The flow runs one way only: 4 sales worth €77k, from 2 insiders, and no purchase. The filings include the largest sale, €37k, on 22 June 2026, which represents 0.0013% of the company's market value.
Between a trade and the moment it shows up on Finanstilsynet DK, the median delay is 2 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
With 9 filings in twelve months, the company is more active than the median of 4 filings across the 74 companies we follow on the same exchange. Since 2011, the database holds 2 purchases and 19 sales by insiders of the company.
For comparison within the same sector, see the insider buying recorded at Anixa Biosciences Inc and Vivos Inc. This summary is built from Finanstilsynet DK disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- Unknown+91.7%Entry DKK 373.20 · Close at T+365 DKK 715.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Zealand Pharma A/S Buy (bullish), based on 12 analysts. Average price target: DKK 398.50.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 309 shares@ DKK 324.600.0005% mcap4.4% of flowShareDanske Bank System Internalizer, DASIISIN DK0060257814DK:1460884
- 646 shares@ DKK 300.590.0011% mcap8.5% of flowShareNasdaq Copenhagen, XCSEISIN DK0060257814DK:1455013
- 1,000 shares@ DKK 278.000.0013% mcap12.2% of flowShareNasdaq Copenhagen, XCSEISIN DK0060257814DK:1449295
- 4,547 shares@ DKK 90.700.0019% mcap18.1% of flowShareOutside a trading venue, XOFFISIN DK0060257814DK:1447494
- 4,000 shares@ DKK 322.800.0060% mcap56.7% of flowShareOutside a trading venue, XOFFISIN DK0060257814DK:1445443
- ●Unknown9M DKK2DK FSA29,403 shares@ DKK 316.29060.043% mcap2.6% of flowShareOutside a trading venue, XOFFISIN DK0060257814DK:1436237
- ◆Unknown493,950 DKK2DK FSA1,500 shares@ DKK 329.300.0023% mcap0.1% of flowShareOutside a trading venue, XOFFISIN DK0060257814DK:1435190
- ▼Unknown467 DKK2DK FSA1 shares@ DKK 467.000.0000% mcap0.0% of flowShareNasdaq Copenhagen, XCSEISIN DK0060257814DK:1407692
- ●Unknown8M DKK2DK FSA15,442 shares@ DKK 487.600.035% mcap2.1% of flowShareOutside a trading venue, XOFFISIN DK0060257814DK:1404877
- ●Unknown44M DKK3DK FSA106,680 shares@ DKK 408.900.20% mcap12.3% of flowShareOutside a trading venue, XOFFISIN DK0060257814DK:1366074
- ◆Unknown516,617 DKK2DK FSA1,217 shares@ DKK 424.500.0024% mcap0.1% of flowShareOutside a trading venue, XOFFISIN DK0060257814DK:1356822
- ●Unknown0DK FSA1,090 shares0ShareOutside a trading venue, XOFFISIN DK0060257814DK:1337157
- ●Unknown0DK FSAShareDK:1335333
- ▼Unknown850,000 DKK2DK FSA1,000 shares@ DKK 850.000.0040% mcap0.2% of flowShareNasdaq Copenhagen (OMX)ISIN DK0060257814DK:1327123
- ▼Unknown31M DKK3DK FSA35,000 shares@ DKK 878.000.14% mcap8.7% of flowShareNasdaq CopenhagenISIN DK0060257814DK:1314117
- ●Unknown206M DKK8DK FSA12 shares0.96% mcap57.9% of flowShareOutside trading VenueISIN DK0060257814DK:1294926
- ●Unknown5M DKK2DK FSA8,008 shares@ DKK 598.000.022% mcap1.3% of flowShareOutside the marketISIN DK0060257814DK:1289217
- ●Unknown510,692 DKK2DK FSA854 shares@ DKK 598.000.0024% mcap0.1% of flowShareOutside the marketISIN DK0060257814DK:1289173
- ▼Unknown1M DKK2DK FSA2,000 shares@ DKK 712.000.0067% mcap0.4% of flowShareNasdaq CopenhagenISIN DK0060257814DK:1284047
- ▼Unknown349,500 DKK2DK FSA500 shares@ DKK 699.000.0016% mcap0.1% of flowShareNasdaq CopenhagenISIN DK0060257814DK:1282221
- ▼Unknown739,000 DKK2DK FSA1,000 shares@ DKK 739.000.0035% mcap0.2% of flowShareNasdaq CopenhagenISIN DK0060257814DK:1280108
- ●Unknown1M DKK2DK FSA8,401 shares@ DKK 138.600.0054% mcap0.3% of flowShareOutside trading venueISIN DK0060257814DK:1279394
- ▲Unknown631,998 DKK2DK FSA1,800 shares@ DKK 351.110.0030% mcap0.2% of flowShareNasdaq CopenhagenISIN DK0060257814DK:1263706Canonical exit: 6 Mar 2024 (T+90)
- ●Unknown7M DKK2DK FSA2 shares@ DKK 3,399,409.000.032% mcap1.9% of flowShareOutside trading VenueISIN DK0060257814DK:1262781
- ●Unknown336,600 DKK2DK FSA1,500 shares@ DKK 224.400.0016% mcap0.1% of flowShareOutside trading venueISIN DK0060257814DK:1247975
25 of 59 declarations
About Zealand Pharma A/S
Zealand Pharma A/S is a Danish biopharmaceutical company focused on developing treatments for metabolic and endocrine diseases. It emphasizes innovation in the field of therapeutic peptides.
